TY - JOUR
T1 - Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test
AU - Pareti, Francesco I.
AU - Cattaneo, Marco
AU - Carpinelli, Luca
AU - Zighetti, Maddalena L.
AU - Bressi, Caterina
AU - Mannucci, Pier Mannuccio
AU - Ruggeri, Zaverio M.
PY - 1996
Y1 - 1996
N2 - We have evaluated platelet function in different subtypes of von Willebrand disease (vWD) by pushing blood through the capillary-sized channels of a glass filter. Patients, including those with type IIB vWD, showed lower than normal platelet retention and increased cumulative number of blood drops passing through the filter as a function of time. In contrast, shear-induced platelet aggregation, measured in the cone-and-plate viscometer, was paradoxically increased in type IIB patients. Treatment with 1-desamino-8-D-arginine vasopressin (DDAVP) tended to normalize the filter test in patients with type I-platelet normal and type I-platelet low vWD, but infusion of a factor VIII/von Willebrand factor (vWF) concentrate lacking the largest vWF multimers was without effect in type 3 patients. Experiments with specific monoclonal antibodies demonstrated that the A1 and A3 domains of vWF, as well as the glycoproteins Ibα and IIb-IIIa on platelets, are required for platelet retention in the filter. Thus, the test may reflect vWF function with regard to both platelet adhesion and aggregation under high shear stress, and provide relevant information on mechanisms involved in primary hemostasis.
AB - We have evaluated platelet function in different subtypes of von Willebrand disease (vWD) by pushing blood through the capillary-sized channels of a glass filter. Patients, including those with type IIB vWD, showed lower than normal platelet retention and increased cumulative number of blood drops passing through the filter as a function of time. In contrast, shear-induced platelet aggregation, measured in the cone-and-plate viscometer, was paradoxically increased in type IIB patients. Treatment with 1-desamino-8-D-arginine vasopressin (DDAVP) tended to normalize the filter test in patients with type I-platelet normal and type I-platelet low vWD, but infusion of a factor VIII/von Willebrand factor (vWF) concentrate lacking the largest vWF multimers was without effect in type 3 patients. Experiments with specific monoclonal antibodies demonstrated that the A1 and A3 domains of vWF, as well as the glycoproteins Ibα and IIb-IIIa on platelets, are required for platelet retention in the filter. Thus, the test may reflect vWF function with regard to both platelet adhesion and aggregation under high shear stress, and provide relevant information on mechanisms involved in primary hemostasis.
UR - http://www.scopus.com/inward/record.url?scp=0029829857&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029829857&partnerID=8YFLogxK
M3 - Article
C2 - 8883287
AN - SCOPUS:0029829857
SN - 0340-6245
VL - 76
SP - 460
EP - 468
JO - Thrombosis and Haemostasis
JF - Thrombosis and Haemostasis
IS - 3
ER -